Genprex Inc.

Genprex Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Genprex Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Genprex Inc..
Log in to see more information.
Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel pr...
GNPX Fundamental Data by TradingView

News

Critical Survey: Genprex (NASDAQ:GNPX) vs. Rocket Pharmaceuticals (NASDAQ:RCKT)
Critical Survey: Genprex (NASDAQ:GNPX) vs. Rocket Pharmaceuticals (NASDAQ:RCKT)

Zolmax Rocket Pharmaceuticals (NASDAQ:RCKT - Get Free Report) and Genprex (NASDAQ:GNPX - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two...\n more…

Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

PR Newswire Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Genprex Collaborators...\n more…

Genprex (NASDAQ:GNPX) versus Rocket Pharmaceuticals (NASDAQ:RCKT) Critical Contrast
Genprex (NASDAQ:GNPX) versus Rocket Pharmaceuticals (NASDAQ:RCKT) Critical Contrast

Ticker Report Genprex (NASDAQ:GNPX - Get Free Report) and Rocket Pharmaceuticals (NASDAQ:RCKT - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two...\n more…

Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes
Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes

PR Newswire Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes Genprex Announces Plans to Launch Separate Company to Focus on the...\n more…

Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
Genprex to Present and Participate at Upcoming September Investor and Industry Conferences

PR Newswire Genprex to Present and Participate at Upcoming September Investor and Industry Conferences Genprex to Present and Participate at Upcoming September Investor and Industry Conferences PR Newswire...\n more…

Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials
Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials

PR Newswire Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials Genprex Releases New Video Featuring Chief Medical Officer...\n more…